2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Selective estrogen receptor modulators in clinical practice: a safety overview.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Selective estrogen receptor (ER) modulators (SERMs) are a class of nonsteroidal compounds that interact with ERs, each with a distinct tissue-specific profile. Depending upon the degree of ER agonism/antagonism at the target tissue, SERMs show efficacy for various indications including osteoporosis, dyspareunia, and breast cancer, and are associated with safety risks.

          Related collections

          Author and article information

          Journal
          Expert Opin Drug Saf
          Expert opinion on drug safety
          Informa Healthcare
          1744-764X
          1474-0338
          Jun 2015
          : 14
          : 6
          Affiliations
          [1 ] Pfizer Laboratories , IPC 004, Ramsgate Road, Sandwich, Kent, CT13 9NJ , UK +44 1304 646911 ; +44 1304 649103 ; amanda.ellis@pfizer.com.
          Article
          10.1517/14740338.2015.1014799
          25936229
          d7ed588f-1c66-4e03-a5b0-99ced71cff85
          History

          selective estrogen receptor modulator,toremifene,tamoxifen,safety,raloxifene,ospemifene,lasofoxifene,fulvestrant,bazedoxifene

          Comments

          Comment on this article